The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K+ channels TREK-1 and TRAAK

H. J. Meadows,C. Chapman,D. Duckworth,R. Kelsell,P. Murdock,S. Nasir,G. Rennie,A. Randall
DOI: https://doi.org/10.1016/S0006-8993(00)03239-X
IF: 3.61
2001-02-16
Brain Research
Abstract:
What problem does this paper attempt to address?